30 Jun 2023 --- Ambrosia Bio, which specializes in novel bioprocesses for sugar replacement, is developing an expression strain for the scalable production of its proprietary enzymes that are used for the conversion of feedstock into the sweetener allulose. Mass production of allulose requires enzymatic conversion of common carbohydrates, but many of the natural enzymes available on the market today lack stability and effectiveness, notes the Israeli food-tech company.
